HK1084403A1 - Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids - Google Patents

Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids

Info

Publication number
HK1084403A1
HK1084403A1 HK06106687.9A HK06106687A HK1084403A1 HK 1084403 A1 HK1084403 A1 HK 1084403A1 HK 06106687 A HK06106687 A HK 06106687A HK 1084403 A1 HK1084403 A1 HK 1084403A1
Authority
HK
Hong Kong
Prior art keywords
asn ile
svdvngevke
rdelfnelln
nileesqvnd
difnslvksv
Prior art date
Application number
HK06106687.9A
Other languages
English (en)
Inventor
Pierre Druilhe
Pierre Daubersies
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of HK1084403A1 publication Critical patent/HK1084403A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/015Hemosporidia antigens, e.g. Plasmodium antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445Plasmodium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205Plasmodium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6018Lipids, e.g. in lipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/822Protozoa

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK06106687.9A 1995-06-13 2006-06-12 Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids HK1084403A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507007A FR2735478B1 (fr) 1995-06-13 1995-06-13 Molecules polypeptidiques de stade pre-erythrocytaire du paludisme

Publications (1)

Publication Number Publication Date
HK1084403A1 true HK1084403A1 (en) 2006-07-28

Family

ID=9479927

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06106687.9A HK1084403A1 (en) 1995-06-13 2006-06-12 Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids

Country Status (13)

Country Link
US (3) US6191270B1 (ja)
EP (2) EP1621547B1 (ja)
JP (2) JPH11508130A (ja)
AT (2) ATE302276T1 (ja)
AU (1) AU719163B2 (ja)
CA (1) CA2221029A1 (ja)
DE (2) DE69638127D1 (ja)
DK (2) DK0833917T3 (ja)
ES (1) ES2248816T3 (ja)
FR (1) FR2735478B1 (ja)
HK (1) HK1084403A1 (ja)
PT (1) PT833917E (ja)
WO (1) WO1996041877A2 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672290B1 (fr) * 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
US20030161840A1 (en) * 1992-10-19 2003-08-28 Institut Pasteur Plasmodium falciparum antigens inducing protective antibodies
FR2735478B1 (fr) * 1995-06-13 1997-08-22 Pasteur Institut Molecules polypeptidiques de stade pre-erythrocytaire du paludisme
FR2771640B1 (fr) * 1997-12-03 2000-02-11 Inst Nat Sante Rech Med Micelles mixtes de lipopeptides pour l'induction d'une reponse immunitaire et leurs utilisations a des fins therapeutiques
EP1201250A1 (en) * 2000-10-25 2002-05-02 SMITHKLINE BEECHAM BIOLOGICALS s.a. Immunogenic compositions comprising liver stage malarial antigens
WO2002092628A2 (fr) * 2001-05-16 2002-11-21 Institut Pasteur Antigenes de plasmodium falciparum et leurs applications vaccinales et diagnostiques
DK1350839T3 (da) 2002-04-05 2010-07-12 Pasteur Institut Identificering af de virulensassocierede regioner RD1 og RD5, hvilket muliggør udvikling af forbedrede vacciner af M. bovis BCG og M. microti
JP5116971B2 (ja) * 2002-10-15 2013-01-09 インターセル アーゲー B群連鎖球菌の接着因子をコードする核酸、b群連鎖球菌の接着因子、およびその使用
KR101035111B1 (ko) * 2004-06-30 2011-05-19 주식회사 엘지생명과학 말라리아 플라스모듐 팔시파룸의 면역학적 측정방법 및이에 사용되는 측정 수단
US8401159B2 (en) * 2005-11-30 2013-03-19 On-Q Telecom Systems Co., Inc. Data provision to a virtual personal assistant for handling calls in a communication system
EP2648744B1 (en) 2010-12-06 2020-06-03 MalVa GmbH Malaria vaccines based on pre-erythrocytic antigens from p. falciparum
CN117069819B (zh) * 2023-09-13 2024-03-19 南华大学 一种黑腹狼蛛抗菌肽lc-amp-i1及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0014815A3 (de) * 1978-12-20 1980-10-29 Ciba-Geigy Ag Peptidderivate, Verfahren zu deren Herstellung und Zwischenprodukte sowie pharmazeutische Präparate mit einer dieser Verbindungen
US6270771B1 (en) * 1988-10-06 2001-08-07 Institut Pasteur Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes
FR2672290B1 (fr) * 1991-02-05 1995-04-21 Pasteur Institut Sequences peptidiques specifiques des stades hepatiques de p. falciparum porteuses d'epitopes capables de stimuler les lymphocytes t.
FR2679909B1 (fr) * 1991-07-31 1995-08-25 Pasteur Institut Polypeptides aptes a induire in vivo des anticorps inhibant l'invasion de globules rouges par des merozouites de p. falciparum, produits apparentes et leur application comme vaccin.
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
FR2735478B1 (fr) * 1995-06-13 1997-08-22 Pasteur Institut Molecules polypeptidiques de stade pre-erythrocytaire du paludisme

Also Published As

Publication number Publication date
CA2221029A1 (fr) 1996-12-27
US6191270B1 (en) 2001-02-20
AU719163B2 (en) 2000-05-04
DK1621547T3 (da) 2010-06-07
AU6309696A (en) 1997-01-09
DE69638127D1 (de) 2010-04-01
FR2735478B1 (fr) 1997-08-22
US20020155441A1 (en) 2002-10-24
EP0833917B1 (fr) 2005-08-17
ATE302276T1 (de) 2005-09-15
US7056518B2 (en) 2006-06-06
WO1996041877A3 (fr) 1997-01-23
DK0833917T3 (da) 2005-12-05
ATE458002T1 (de) 2010-03-15
PT833917E (pt) 2005-11-30
US20050287166A1 (en) 2005-12-29
ES2248816T3 (es) 2006-03-16
JP2009000104A (ja) 2009-01-08
EP1621547B1 (fr) 2010-02-17
DE69635077T2 (de) 2006-05-18
JPH11508130A (ja) 1999-07-21
DE69635077D1 (de) 2005-09-22
EP1621547A1 (fr) 2006-02-01
WO1996041877A2 (fr) 1996-12-27
FR2735478A1 (fr) 1996-12-20
EP0833917A2 (fr) 1998-04-08

Similar Documents

Publication Publication Date Title
HK1084403A1 (en) Conjugates of malarial pre-erythrocytic stage polypeptide molecules and lipids
AU629649B2 (en) Novel procoagulant proteins
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
ATE86636T1 (de) F antigene vom menschlichen immunodefizienz-virus und deren verwendungen.
NZ503007A (en) Conjugates that contain the homeodomain of antennapedia
EP0875567A3 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
CA2249180A1 (en) Methods for recombinant microbial production of bpi-fusion proteins and bpi-derived peptides
EP0330878A3 (en) Anti-ras protein-antibodies
WO1999002708A8 (en) Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein
WO1996002572A3 (fr) Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci
AU1444699A (en) Single-chain polypeptides comprising troponin i and troponin
WO1999033989A3 (en) Rantes mutants and therapeutic applications thereof
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
CA2163805A1 (en) Novel activating factor of leukocytes
PL347943A1 (en) Moraxella catarrhalis basb034 polypeptides and uses thereof
CA2083286A1 (en) Recombinant fibrinogenases, preparation and use thereof
EP0290029A3 (en) (19-alanine) calcitonin
Bolen et al. Cytotoxic protein from the yeast Pichia inositovora
Allen Protein V: A IgG binding factor.
IT1261676B (it) Proteine ricombinanti, vettori per l'espressione e loro usi.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130612